Allied-Market-Research-mobile

Coming Up With New Logo

Cart
0
Get 20% Free Customization In This Report

North America Dendritic Cell Cancer Vaccine Market by Product Type [CreaVax, Sipuleucel-T (Provenge), and Others] and by End Users (Pediatrics and Adults) - Opportunities and Industry Forecasts, 2017-2023

  • ID: LI 173519
  • Mar 2018
  • NA pages
  • Price: $4028
$2592

Dendritic cells (DCs) refer to rare kinds of leukocytes. They are used in therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. Isolated DCs loaded with tumor antigen ex vivo that are administered as a cellular vaccine are found to induce protective & therapeutic anti-tumor immunity in experimental animals.

An increase in the prevalence of cancer and improvement of technology such as drug innovations regarding cancer drive the market growth. However, stringent regulatory procedures restrain the market. Upsurge in the awareness of cancer and their available therapies in the market, along with an increase in healthcare expenditure are expected to provide opportunities for the market growth.

This report segments the North American dendritic cell cancer vaccine market based on type, end user, and country. Based on type, it is categorized into CreaVax, Sipuleucel-T (Provenge), and others. Based on end user, it is classified into pediatrics and adults. By country, it has been analyzed across the U.S., Canada, and Mexico.

The key players of the dendritic cell cancer vaccine market are 3M Company, Argos Therapeutics, Creagene, Dendreon Corporation, Elios Therapeutics, ImmunoCellular Therapeutics, Merck & Co., Inc., GlaxoSmithKline plc, Northwest Biotherapeutics, Inc., and Tella Incorporation.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate imminent investment pockets.
  • The report provides information about the current and upcoming trends in the market from 2016 to 2023, which helps determine prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
  • Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market have been provided.
  • Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the market.

North America Dendritic Cell Cancer Vaccine Market Key Segments:

By Product Type

  • CreaVax
  • Sipuleucel-T (Provenge)
  • Others

By End User

  • Pediatrics
  • Adults

By Country

  • U.S.
  • Canada
  • Mexico
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 NORTH AMERICA DENDRITIC CELL CANCER VACCINE MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CREAVAX

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. SIPULEUCEL-T (PROVENGE)

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. OTHERS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5 NORTH AMERICA DENDRITIC CELL CANCER VACCINE MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. PEDIATRICS

5.2.1. Market size and forecast

5.3. ADULTS

5.3.1. Market size and forecast

Chapter: 6 NORTH AMERICA DENDRITIC CELL CANCER VACCINE MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America North America Dendritic Cell Cancer Vaccine Market by Product Type
6.2.5. North America North America Dendritic Cell Cancer Vaccine Market by End User

Chapter: 7 COMPANY PROFILES

7.1. 3M COMPANY

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. ARGOS THERAPEUTICS

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. CREAGENE

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. DENDREON CORPORATION

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. ELIOS THERAPEUTICS

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. IMMUNOCELLULAR THERAPEUTICS

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. MERCK & CO., INC.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. GLAXOSMITHKLINE PLC

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. NORTHWEST BIOTHERAPEUTICS, INC.

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. TELLA INCORPORATION

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

 

 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 

Get More Information About This Report

For any queries about purchasing this report, For any queries, please fill the form below:

Please input the above text in the input box or click refresh

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASK
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Readings

 
 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts